These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12591842)

  • 1. Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention.
    Hamon M; Fradin S; Denizet A; Filippi-Codaccioni E; Grollier G; Morello R
    Heart; 2003 Mar; 89(3):321-5. PubMed ID: 12591842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
    Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
    Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.
    Winkelmann BR; Nauck M; Klein B; Russ AP; Böhm BO; Siekmeier R; Ihnken K; Verho M; Gross W; März W
    Ann Intern Med; 1996 Jul; 125(1):19-25. PubMed ID: 8644984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
    Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
    J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction.
    Arbustini E; Grasso M; Fasani R; Klersy C; Diegoli M; Porcu E; Banchieri N; Fortina P; Danesino C; Specchia G
    Br Heart J; 1995 Dec; 74(6):584-91. PubMed ID: 8541160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin converting enzyme genetic polymorphism in acute coronary syndrome--ACE polymorphism as a risk factor of acute coronary syndrome.
    Park HY; Kwon HM; Kim D; Jang Y; Shim WH; Cho SY; Kim HS
    J Korean Med Sci; 1997 Oct; 12(5):391-7. PubMed ID: 9364295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
    Koch W; Mehilli J; von Beckerath N; Böttiger C; Schömig A; Kastrati A
    J Am Coll Cardiol; 2003 Jun; 41(11):1957-61. PubMed ID: 12798565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina.
    Leatham E; Barley J; Redwood S; Hussein W; Carter N; Jeffery S; Bath PM; Camm A
    J Hum Hypertens; 1994 Aug; 8(8):635-8. PubMed ID: 7990100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
    Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
    Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.
    Lindpaintner K; Pfeffer MA; Kreutz R; Stampfer MJ; Grodstein F; LaMotte F; Buring J; Hennekens CH
    N Engl J Med; 1995 Mar; 332(11):706-11. PubMed ID: 7854377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery.
    Völzke H; Engel J; Kleine V; Schwahn C; Dahm JB; Eckel L; Rettig R
    Chest; 2002 Jul; 122(1):31-6. PubMed ID: 12114335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D allele of the angiotensin-converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction.
    Yoshida M; Iwai N; Ohmichi N; Izumi M; Nakamura Y; Kinoshita M
    Int J Cardiol; 1999 Jul; 70(2):119-25. PubMed ID: 10454299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus.
    Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):478-86. PubMed ID: 22679279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study.
    Pfohl M; Koch M; Prescod S; Haase KK; Häring HU; Karsch KR
    Eur Heart J; 1999 Sep; 20(18):1318-25. PubMed ID: 10462466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and vasospastic angina.
    Kuroki S; Ikeda U; Maeda Y; Sekiguchi H; Shimada K
    Clin Cardiol; 1997 Oct; 20(10):873-6. PubMed ID: 9377825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.
    Bray PF; Cannon CP; Goldschmidt-Clermont P; Moyé LA; Pfeffer MA; Sacks FM; Braunwald E
    Am J Cardiol; 2001 Aug; 88(4):347-52. PubMed ID: 11545752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of I/D angiotensin-converting enzyme gene polymorphism in healthy subjects. Findings after follow-up of six years.
    Di Pasquale P; Cannizzaro S; Scalzo S; Maringhini G; Pipitone F; Fasullo S; Giubilato A; Ganci F; Vitale G; Sarullo FM; Paterna S
    Acta Cardiol; 2005 Aug; 60(4):427-35. PubMed ID: 16128377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.